Relay Therapeutics Inc. (NASDAQ:RLAY) went up by 7.27% from its latest closing price compared to the recent 1-year high of $57.59. The company’s stock price has collected 5.37% of gains in the last five trading sessions. Press Release reported on 01/06/21 that Relay Therapeutics to Present at 39th Annual J.P. Morgan Healthcare Conference
Is It Worth Investing in Relay Therapeutics Inc. (NASDAQ :RLAY) Right Now?
Opinions of the stock are interesting as 5 analysts out of 6 who provided ratings for Relay Therapeutics Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 1 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $55.60, which is $15.6 above the current price. RLAY currently public float of 45.40M and currently shorts hold a 11.84% ratio of that float. Today, the average trading volume of RLAY was 322.81K shares.
RLAY’s Market Performance
RLAY stocks went up by 5.37% for the week, with a monthly drop of -21.46% and a quarterly performance of -5.64%. The volatility ratio for the week stands at 9.27% while the volatility levels for the past 30 days are set at 8.27% for Relay Therapeutics Inc.. The simple moving average for the period of the last 20 days is -9.35% for RLAY stocks with a simple moving average of -4.42% for the last 200 days.
Analysts’ Opinion of RLAY
Many brokerage firms have already submitted their reports for RLAY stocks, with H.C. Wainwright repeating the rating for RLAY by listing it as a “Buy.” The predicted price for RLAY in the upcoming period, according to H.C. Wainwright is $57 based on the research report published on December 15th of the previous year 2020.
JMP Securities, on the other hand, stated in their research note that they expect to see RLAY reach a price target of $66. The rating they have provided for RLAY stocks is “Mkt Outperform” according to the report published on December 08th, 2020.
H.C. Wainwright gave a rating of “Buy” to RLAY, setting the target price at $54 in the report published on November 05th of the previous year.
RLAY Trading at -13.69% from the 50-Day Moving Average
After a stumble in the market that brought RLAY to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -30.54% of loss for the given period.
Volatility was left at 8.27%, however, over the last 30 days, the volatility rate increased by 9.27%, as shares sank -20.10% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +8.23% upper at present.
During the last 5 trading sessions, RLAY rose by +5.37%, in comparison to the 20-day moving average, which settled at $43.62. In addition, Relay Therapeutics Inc. saw -3.75% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for RLAY
The total capital return value is set at -20.92, while invested capital returns managed to touch -18.78.
Based on Relay Therapeutics Inc. (RLAY), the company’s capital structure generated 6.95 points at debt to equity in total, while total debt to capital is 6.50.
The liquidity ratio also appears to be rather interesting for investors as it stands at 30.08.